IWC
CHRS icon

Integrated Wealth Concepts’s Coherus Oncology CHRS Stock Holding History

Integrated Wealth Concepts’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84K Buy
+4,886
New +$7.98K ﹤0.01% 4798

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Integrated Wealth Concepts's CHRS Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Coherus Oncology (CHRS) in Q2 2026: 4,886 shares worth $6.84K. The stake represents ﹤0.01% of the portfolio and ranks #4798 among its holdings.

146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Integrated Wealth Concepts held 4,886 shares of Coherus Oncology worth $6.84K as of Q2 2026.
  • Coherus Oncology was a new Integrated Wealth Concepts position in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4798 holding.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.